Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.

JAMA - 2 Mar 2021

Moore John P, Offit Paul A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to COVID-19
Share to COVID-19 Vaccines
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA, Messenger

Share to SARS-CoV-2

Share to Virus Shedding

Source

Identifiers

PMID: 33507218
DOI: 10.1001/jama.2021.1114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.PMID 33507218Read ↗

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.Semantic proximity Read ↗

The vaccines can keep up with the SARS-CoV-2 mutations.Semantic proximity Read ↗

SARS-CoV-2 evolution and vaccines: cause for concern?Semantic proximity Read ↗

Viruses, variants and vaccines.Semantic proximity Read ↗

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.Semantic proximity Read ↗

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 VariantsSemantic proximity Read ↗

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – CorrespondenceSemantic proximity Read ↗

The challenge of emerging SARS-CoV-2 mutants to vaccine development.Semantic proximity Read ↗

Insights into SARS-CoV-2 evolution, potential antivirals, and vaccinesSemantic proximity Read ↗

SARS-CoV-2 Variants and Vaccines.Semantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.